Foresite Capital Management III as of Sept. 30, 2019
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 14 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 17.2 | $45M | 2.4M | 19.22 | |
| Alder Biopharmaceuticals | 17.2 | $45M | 2.4M | 18.86 | |
| Blueprint Medicines (BPMC) | 15.7 | $41M | 559k | 73.47 | |
| Immunomedics | 9.9 | $26M | 2.0M | 13.26 | |
| Ascendis Pharma A S (ASND) | 7.5 | $20M | 204k | 96.32 | |
| Myokardia | 6.0 | $16M | 299k | 52.15 | |
| Aimmune Therapeutics | 4.9 | $13M | 612k | 20.94 | |
| Epizyme | 3.9 | $10M | 998k | 10.31 | |
| Acceleron Pharma | 3.9 | $10M | 255k | 39.51 | |
| Natera (NTRA) | 3.6 | $9.4M | 287k | 32.80 | |
| Audentes Therapeutics | 3.4 | $8.9M | 315k | 28.09 | |
| Replimune Group (REPL) | 3.0 | $7.9M | 570k | 13.90 | |
| Cymabay Therapeutics | 3.0 | $7.7M | 1.5M | 5.12 | |
| Biohaven Pharmaceutical Holding | 0.8 | $2.2M | 53k | 41.73 |
